Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
My insurer, Blue Cross Blue Shield of Massachusetts, had recently informed me the drug would no longer be covered when my health plan renews in March
Semaglutide a GLP-1 receptor agonist is already well established in UK practice for type 2 diabetes mellitus in the form of Ozempic and Wegovy for obesity, both manufactured by Novo Nordisk
Nothing in this guide is medical advice
Therapeutic use of GLP-1 tends to normalize alpha and beta cell sensitivity to glucose leading to improved glycemic control and reduced diabetic toxicity 7
That sounds appealing on the surface but there are important caveats employers should understand before jumping in: The $449 price is a starting point
Participants started with different A1c levels and body weights, took different background medications, and were followed for different lengths of time
US$ 25.42
US$ 28.15
US$ 28.14
US$ 28.63
US$ 25.06
US$ 24.61
US$ 22.18
US$ 28.38
US$ 25.43
US$ 21.27
US$ 23.69
US$ 21.82
US$ 20.25
